EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?

Gabriele Giuseppe Pagliari iD, Francesca Colonese, Stefania Canova iD, Maria Ida Abbate, Luca Sala iD, Francesco Petrella iD, Thoma Dario Clementi, Diego Luigi Cortinovis iD

Cancers · 21.11.2024 · 16 (23) · 3892

DOI: 10.3390/cancers16233892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 21.11.2024. Verfasst von Gabriele Giuseppe Pagliari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to a modern view, cancer no longer follows a purely mechanistic model. Rather, a tumor is conceived as a more complex structure, composed of cancer cells, the activities of which may interact and reshape the so-called tumor microenvironment (TME), leading to preservation of specific tumoral niches and promoting the survival of tumoral stem cells. Background/Objective: Therapeutic strategies must deal with this unique cancer architecture in the near future by widening their range of activities outside the cancer cells and rewiring a TME to ensure it is hostile to cancer growth. Therefore, an intratumoral therapeutic strategy may open the door to a new type of anticancer activity, one that directly injures the tumoral structure while also eliciting an influence on the TME through local and systemic immunomodulation. This review would like to assess the current situation of intratumoral strategies and their clinical implications.

Methods

We analyzed data from phase I, II, and III trials, comprehensive reviews and relevant clinical and preclinical research, from robust databases, like PUBMED, EMBASE, Cochrane Library, and clinicaltrials.gov.

Results

Intratumoral strategies can be quite variable. It is possible the injection and inhalation of traditional antiblastic agents or immunomodulant agents, or intrapleural administration. Ablation strategy is available, both thermal and photodynamic method. Moreover, TTfields and NPs are analyzed and also brachytherapy is mentioned. Intratumoral therapy can find space in “adjuvant”/perioperative or metastatic settings. Finally, intratumoral strategies allow to synergize their activities with systemic therapies, guaranteeing better local and systemic disease control.

Conclusions

Intratumoral strategies are overall promising. Antiblastic/immunomodulant injection and NPs use are especially interesting and intriguing. But, there is generally a lack of phase II and III trials, in particular NPs use need additional experimentation and clinical studies.

Schlagwörter

Stichwörter der Autor:innen

intratumoral therapieslocoregional treatmentslung cancer

Autor:innen und Institutionen

  • Medical Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • Medicine and Surgery Department, Milano Bicocca University, 20126 Milan, Italy.
  • Department of Thoracic Surgery, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

ORCID-Profile: Gabriele Giuseppe Pagliari, Stefania Canova, Luca Sala, Francesco Petrella, Diego Luigi Cortinovis

Zitieren

APA

Pagliari, G. G., Colonese, F., Canova, S., Abbate, M. I., Sala, L., Petrella, F., Clementi, T. D., & Cortinovis, D. L. (2024). Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?. Cancers, 16(23), 3892. https://doi.org/10.3390/cancers16233892

Vancouver

Pagliari GG, Colonese F, Canova S, Abbate MI, Sala L, Petrella F, et al. Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?. Cancers. 2024;16(23):3892. doi:10.3390/cancers16233892

BibTeX
@article{Pagliari2024,
  author = {Pagliari, Gabriele Giuseppe and Colonese, Francesca and Canova, Stefania and Abbate, Maria Ida and Sala, Luca and Petrella, Francesco and Clementi, Thoma Dario and Cortinovis, Diego Luigi},
  title = {Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {23},
  pages = {3892},
  doi = {10.3390/cancers16233892}
}
Kostenlos starten →